Although most people do not experience serious reactions to Campath^® (alemtuzumab), some sort of side effect can be expected. Fortunately, such problems are usually mild and easily treated.

In clinical studies, some of the most commonly reported reactions to this drug included:

Low white blood cell counts -- in up to 97 percent of people
Low red blood cell counts (anemia) -- up to 76 percent
Infections -- up to 74 percent
Low platelet counts -- up to 71 percent
Fever -- up to 69 percent.

(Click Campath Side Effects to learn more about possible adverse reactions to this drug, including potentially serious ones that may require medical attention.)

5 Easy Tips to Manage Visitors During Cancer Treatment

List of references (click here)

Written by/reviewed by: Susan Lakey, PharmD, MPH, BCPP

Last reviewed by: Kristi Monson, PharmD

Referring Pages:

Articles

Advertise with Us

About eMedTV

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.